High-activity iodine-125 endocurietherapy for head and neck tumors.
Inoperable solid tumor recurrence within a surgical bed or within a previously irradiated field usually responds poorly to re-treatment with conventional external beam irradiation (EXRT) and/or chemotherapy. We present a new, alternative method of re-treatment used in two patients with recurrent head and neck cancer involving the parotid (adenocarcinoma) and neck nodes (squamous cell carcinoma). These patients were successfully re-treated with high-activity 125iodine (I-125) permanent implantation.
Kumar
P P
PP
Department of Radiology, University of Nebraska College of Medicine, Omaha 68105.
Good
R R
RR
Yonkers
A J
AJ
Ogren
F P
FP
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000556:secondary; D000368:Aged; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000556:secondary; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010307:Parotid Neoplasms / Q000532:radiotherapy / Q000556:secondary; D011879:Radiotherapy Dosage
D007457:Iodine Radioisotopes